CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Dasatinib

达沙替尼 杂质对照品Dasatinib Impurities

56 个杂质条目56 impurity entries

本页汇总 达沙替尼 的 56 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 56 impurity reference standards of Dasatinib. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 达沙替尼(Dasatinib)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesRP-LC Method Development and Validation for Dasatinib Forced Degradation Study: Isolation and Structural Characterization by NMR and HRMS
    Journal of chromatographic science · 2024 · Kavitapu DR et al.  ·  PMID 37340779  ·  DOI
  2. 杂质研究Impurity studiesA Quality by Design (QbD) driven gradient high performance liquid chromatography method development for the simultaneous estimation of dasatinib and nilotinib in lipid nanocarriers
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2024 · Sen S, Ranjan OP  ·  PMID 38991258  ·  DOI
  3. 杂质研究Impurity studiesInvestigational Study of DASATINIB N-Oxide Impurity in Different Diluents
    Journal of chromatographic science · 2023 · Prasad Ketha NVD, Kolli D  ·  PMID 36222064  ·  DOI
  4. 分析方法Analytical MethodsA validated UPLC-MS/MS method for simultaneous determination of imatinib, dasatinib and nilotinib in human plasma
    Journal of pharmaceutical analysis · 2017 · Zeng J et al.  ·  PMID 29404062  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisThe synthesis of Bcr-Abl inhibiting anticancer pharmaceutical agents imatinib, nilotinib and dasatinib
    Organic & biomolecular chemistry · 2013 · Deadman BJ et al.  ·  PMID 23247657  ·  DOI

达沙替尼 —— 原料药与杂质对照品Dasatinib — drug substance & impurities

共 57 个条目(含原料药本体)57 items incl. the drug substance
Dasatinib structure
原料药 APIAPI
达沙替尼Dasatinib
Dasatinib
CAS No.302962-49-8
Chemical FormulaC22H26ClN7O2S
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 1 structure
1
达沙替尼杂质1Dasatinib Impurity 1
Dasatinib Impurity 1
CAS No.910297-53-9
Chemical FormulaC22H24ClN7O3S
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 2 structure
2
达沙替尼杂质2Dasatinib Impurity 2
Dasatinib Impurity 2
CAS No.910297-62-0
Chemical FormulaC24H28ClN7O3S
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 3 structure
3
达沙替尼杂质3Dasatinib Impurity 3
Dasatinib Impurity 3
CAS No.1184919-23-0
Chemical FormulaC22H27N7O2S
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 4 structure
4
达沙替尼杂质4Dasatinib Impurity 4
Dasatinib Impurity 4
CAS No.302964-08-5
Chemical FormulaC16H13Cl2N5OS
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 5 structure
5
达沙替尼杂质5Dasatinib Impurity 5
Dasatinib Impurity 5
CAS No.910297-61-9
Chemical FormulaC36H34Cl2N12O2S2
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 6 Hydrochloride structure
6
达沙替尼杂质6 盐酸盐Dasatinib Impurity 6 Hydrochloride
Dasatinib Impurity 6 Hydrochloride
CAS No.1852573-26-2
Chemical FormulaC20H22ClN7OS·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 6 structure
6
达沙替尼杂质6Dasatinib Impurity 6
Dasatinib Impurity 6
CAS No.910297-51-7
Chemical FormulaC20H22ClN7OS
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 7 structure
7
达沙替尼杂质7Dasatinib Impurity 7
Dasatinib Impurity 7
CAS No.910297-52-8
Chemical FormulaC22H26ClN7O3S
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 8 structure
8
达沙替尼杂质8Dasatinib Impurity 8
Dasatinib Impurity 8
CAS No.910297-57-3
Chemical FormulaC22H26ClN7O3S
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 9 structure
9
达沙替尼杂质9Dasatinib Impurity 9
Dasatinib Impurity 9
CAS No.1159977-25-9
Chemical FormulaC22H27N7O3S
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 10 structure
10
达沙替尼杂质10Dasatinib Impurity 10
Dasatinib Impurity 10
CAS No.2468737-81-5
Chemical FormulaC16H13Cl2N5OS
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 11 structure
11
达沙替尼杂质11Dasatinib Impurity 11
Dasatinib Impurity 11
CAS No.1417651-54-7
Chemical FormulaC21H16Cl3N7OS
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 12 structure
12
达沙替尼杂质12Dasatinib Impurity 12
Dasatinib Impurity 12
CAS No.2468737-80-4
Chemical FormulaC27H22Cl2N8O2S2
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 14 structure
14
达沙替尼杂质14Dasatinib Impurity 14
Dasatinib Impurity 14
CAS No.2468737-83-7
Chemical FormulaC22H26ClN7O2S
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 18 structure
18
达沙替尼杂质18Dasatinib Impurity 18
Dasatinib Impurity 18
CAS No.2048106-50-7
Chemical FormulaC22H26ClN7O2S
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 19 structure
19
达沙替尼杂质19Dasatinib Impurity 19
Dasatinib Impurity 19
CAS No.2468737-87-1
Chemical FormulaC28H39N9O3S
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 21 structure
21
达沙替尼杂质21Dasatinib Impurity 21
Dasatinib Impurity 21
CAS No.1245157-85-0
Chemical FormulaC24H28ClN7O3S
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 24 structure
24
达沙替尼杂质24Dasatinib Impurity 24
Dasatinib Impurity 24
CAS No.910297-71-9
Chemical FormulaC16H13Cl2N5O2S
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 26 structure
26
达沙替尼杂质26Dasatinib Impurity 26
Dasatinib Impurity 26
CAS No.1251716-89-8
Chemical FormulaC9H7ClN4O2S
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 27 structure
27
达沙替尼杂质27Dasatinib Impurity 27
Dasatinib Impurity 27
CAS No.302964-24-5
Chemical FormulaC11H10ClN3OS
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 28 structure
28
达沙替尼杂质28Dasatinib Impurity 28
Dasatinib Impurity 28
CAS No.1184914-03-1
Chemical FormulaC11H11N3OS
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 29 structure
29
达沙替尼杂质29Dasatinib Impurity 29
Dasatinib Impurity 29
CAS No.2468737-77-9
Chemical FormulaC11H9Cl2N3OS
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 30 structure
30
达沙替尼杂质30Dasatinib Impurity 30
Dasatinib Impurity 30
CAS No.2468737-78-0
Chemical FormulaC11H9Cl2N3OS
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 31 structure
31
达沙替尼杂质31Dasatinib Impurity 31
Dasatinib Impurity 31
CAS No.2468737-79-1
Chemical FormulaC11H9Cl2N3OS
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 33 (N-Nitroso Dasatinib Impurity 6) structure
33
达沙替尼杂质33 (N-亚硝基达沙替尼杂质6)Dasatinib Impurity 33 (N-Nitroso Dasatinib Impurity 6)
Dasatinib Impurity 33 (N-Nitroso Dasatinib Impurity 6)
CAS No.2135905-86-9
Chemical FormulaC20H21ClN8O2S
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 37 structure
37
达沙替尼杂质37Dasatinib Impurity 37
Dasatinib Impurity 37
CAS No.1416737-47-7
Chemical FormulaC12H15BrClNO3
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 56 structure
56
达沙替尼杂质56Dasatinib Impurity 56
Dasatinib Impurity 56
CAS No.2748587-50-8
Chemical FormulaC20H22ClN5O2S
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 62 structure
62
达沙替尼杂质62Dasatinib Impurity 62
Dasatinib Impurity 62
CAS No.6387-14-0
Chemical FormulaC7H8ClNO3S
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 63 structure
63
达沙替尼杂质63Dasatinib Impurity 63
Dasatinib Impurity 63
CAS No.617-07-2
Chemical FormulaC15H16N2O
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 64 structure
64
达沙替尼杂质64Dasatinib Impurity 64
Dasatinib Impurity 64
CAS No.40686-05-3
Chemical FormulaC15H16N2O7S2
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 70 structure
70
达沙替尼杂质70Dasatinib Impurity 70
Dasatinib Impurity 70
CAS No.54198-86-6
Chemical FormulaC5H3Cl3N2
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 81 structure
81
达沙替尼杂质81Dasatinib Impurity 81
Dasatinib Impurity 81
CAS No.127116-19-2
Chemical FormulaC11H17ClN4O
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 83 structure
83
达沙替尼杂质83Dasatinib Impurity 83
Dasatinib Impurity 83
CAS No.1025814-13-4
Chemical FormulaC20H24ClN7O2S
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 84 structure
84
达沙替尼杂质84Dasatinib Impurity 84
Dasatinib Impurity 84
CAS No.1044209-24-6
Chemical FormulaC14H20ClNO3
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 85 structure
85
达沙替尼杂质85Dasatinib Impurity 85
Dasatinib Impurity 85
CAS No.755031-80-2
Chemical FormulaC7H7ClIN
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 88 structure
88
达沙替尼杂质88Dasatinib Impurity 88
Dasatinib Impurity 88
CAS No.223580-51-6
Chemical FormulaC11H10ClN3OS
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 89 structure
89
达沙替尼杂质89Dasatinib Impurity 89
Dasatinib Impurity 89
CAS No.1159977-13-5
Chemical FormulaC25H30ClN7O3S
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 90 structure
90
达沙替尼杂质90Dasatinib Impurity 90
Dasatinib Impurity 90
CAS No.30273-00-8
Chemical FormulaC7H7Cl2N
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 91 structure
91
达沙替尼杂质91Dasatinib Impurity 91
Dasatinib Impurity 91
CAS No.62077-27-4
Chemical FormulaC7H7Cl2N
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 92 structure
92
达沙替尼杂质92Dasatinib Impurity 92
Dasatinib Impurity 92
CAS No.62077-26-3
Chemical FormulaC7H7Cl2N
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 99 structure
99
达沙替尼杂质99Dasatinib Impurity 99
Dasatinib Impurity 99
CAS No.1780-26-3
Chemical FormulaC5H4Cl2N2
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 104 structure
104
达沙替尼杂质104Dasatinib Impurity 104
Dasatinib Impurity 104
CAS No.50270-27-4
Chemical FormulaC5HCl3N2O
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 107 structure
107
达沙替尼杂质107Dasatinib Impurity 107
Dasatinib Impurity 107
CAS No.1349900-63-5
Chemical FormulaC11H12ClNO3
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 108 structure
108
达沙替尼杂质108Dasatinib Impurity 108
Dasatinib Impurity 108
CAS No.1258411-46-9
Chemical FormulaC11H10ClN3O2
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 109 structure
109
达沙替尼杂质109Dasatinib Impurity 109
Dasatinib Impurity 109
CAS No.2099694-51-4
Chemical FormulaC10H7Cl3N4
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 110 structure
110
达沙替尼杂质110Dasatinib Impurity 110
Dasatinib Impurity 110
CAS No.1111850-50-0
Chemical FormulaC12H11Cl2N3
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 111 structure
111
达沙替尼杂质111Dasatinib Impurity 111
Dasatinib Impurity 111
CAS No.1245157-42-9
Chemical FormulaC15H20N6O3S
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 114 structure
114
达沙替尼杂质114Dasatinib Impurity 114
Dasatinib Impurity 114
CAS No.2099694-53-6
Chemical FormulaC18H24ClN5O
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 121 structure
121
达沙替尼杂质121Dasatinib Impurity 121
Dasatinib Impurity 121
CAS No.61456-95-9
Chemical FormulaC8H9Cl2N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 122 structure
122
达沙替尼杂质122Dasatinib Impurity 122
Dasatinib Impurity 122
CAS No.302964-27-8
Chemical FormulaC15H11Cl2N5OS
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 123 structure
123
达沙替尼杂质123Dasatinib Impurity 123
Dasatinib Impurity 123
CAS No.863127-76-8
Chemical FormulaC12H14ClNO2
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 124 structure
124
达沙替尼杂质124Dasatinib Impurity 124
Dasatinib Impurity 124
CAS No.95-69-2
Chemical FormulaC7H8ClN
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 125 structure
125
达沙替尼杂质125Dasatinib Impurity 125
Dasatinib Impurity 125
CAS No.5623-99-4
Chemical FormulaC8H12N4
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 129 structure
129
达沙替尼杂质129Dasatinib Impurity 129
Dasatinib Impurity 129
CAS No.54961-35-2
Chemical FormulaC4H8N2O
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 130 structure
130
达沙替尼杂质130Dasatinib Impurity 130
Dasatinib Impurity 130
CAS No.2112837-79-1
Chemical FormulaC21H22ClN7O2S
Purity>95%询价On request
10mg25mg50mg100mg
Dasatinib Impurity 86-d4 structure
86-D4
达沙替尼杂质86-d4Dasatinib Impurity 86-d4
Dasatinib Impurity 86-d4
CAS No.1160357-16-3
Chemical FormulaC6H10D4N2O
Purity>95%询价On request
本品种含亚硝胺类杂质条目。亚硝胺杂质属于 ICH M7 关注的潜在致突变杂质,建议在方法开发中纳入专属性考察。This list includes nitrosamine entries. Nitrosamines are potential mutagenic impurities under ICH M7 and should be covered by a specific method.

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

达沙替尼 —— 研究文献与合成路线Dasatinib — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 达沙替尼 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Dasatinib. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. RP-LC Method Development and Validation for Dasatinib Forced Degradation Study: Isolation and Structural Characterization by NMR and HRMS
    Kavitapu DR, Murty JNSRC, Maruthapillai A, et al. · Journal of chromatographic science · 2024
  2. Investigational Study of DASATINIB N-Oxide Impurity in Different Diluents
    Prasad Ketha NVD, Kolli D · Journal of chromatographic science · 2023 · 被引 1cited 1
  3. Enhanced Anticancer Activity of Nanoformulation of Dasatinib against Triple-Negative Breast Cancer by Reduced Metabolic Degradation
    Bahman F, Pittalà V, Haider M, et al. · 2021
  4. Determination of dasatinib in the tablet dosage form by ultra high performance liquid chromatography, capillary zone electrophoresis, and sequential injection analysis
    Gonzalez AG, Taraba L, Hraníček J, et al. · Journal of separation science · 2017 · 被引 5cited 5
  5. Development of a specific and sensitive sandwich enzyme-linked immunosorbent assay for the quantification of dasatinib
    Kataoka H, Saita T, Yamamoto Y, et al. · Analytical biochemistry · 2023 · 被引 2cited 2
  6. A simple isotope-labeled UHPLC-MS/MS assay for simultaneous quantification of methotrexate, imatinib and dasatinib
    Zhang Y, Liu Y, Tan L · Bioanalysis · 2021

合成与制备工艺专利Synthesis & process patents

  1. SYNTHESIS PROCESS OF DASATINIB AND INTERMEDIATE THEREOF
    YAN RONG, YANG HAO, HOU WEN, XU YONGXIANG · 公开号 WO2011095126WO2011095126 · 2011
  2. PROCESS FOR PREPARING CRYSTALLINE DASATINIB MONOHYDRATE
    GORE VINAYAK GOVIND, PATKAR LAXMIKANT, BAGUL AMIT, VIJAYKAR PRIYESH SURENDRA, et al. · 公开号 WO2010139980WO2010139980 · 2010
  3. POLYMORPHS OF DASATINIB AND PROCESS FOR PREPARATION THEREOF
    SIMO ONDREJ, FILIPCIK JIRI, MARTAUS ALEXANDR, JEGOROV ALEXANDR, et al. · 公开号 US2010256158US2010256158 · 2010
  4. POLYMORPHS OF DASATINIB AND PROCESS FOR PREPARATION THEREOF
    VRASPIR PAVEL, GAVENDA ALES, GABRIEL ROMAN, JEGOROV ALEXANDR · 公开号 WO2010062715WO2010062715 · 2010
  5. Novel method for synthesizing dasatinib
    WEN HOU, YONGXIANG XU, RONG YAN, HAO YANG · 公开号 CN101845045CN101845045 · 2010

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

达沙替尼 杂质谱研究要点Dasatinib — impurity profiling notes

下面这些是拿到 达沙替尼 的 57 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 57 impurity entries for Dasatinib, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances